1. Home
  2. LENZ vs GEVO Comparison

LENZ vs GEVO Comparison

Compare LENZ & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LENZ Therapeutics Inc.

LENZ

LENZ Therapeutics Inc.

HOLD

Current Price

$8.29

Market Cap

609.5M

Sector

Health Care

ML Signal

HOLD

Logo Gevo Inc.

GEVO

Gevo Inc.

HOLD

Current Price

$2.76

Market Cap

568.2M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
LENZ
GEVO
Founded
2019
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
609.5M
568.2M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
LENZ
GEVO
Price
$8.29
$2.76
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$45.60
$6.42
AVG Volume (30 Days)
1.0M
4.1M
Earning Date
03-24-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.82
EPS
N/A
N/A
Revenue
$19,088,000.00
$711,000.00
Revenue This Year
$162.79
$19.44
Revenue Next Year
$170.32
$5.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$8.40
$0.92
52 Week High
$50.19
$2.95

Technical Indicators

Market Signals
Indicator
LENZ
GEVO
Relative Strength Index (RSI) 27.19 74.68
Support Level N/A $2.25
Resistance Level $12.70 $2.95
Average True Range (ATR) 0.83 0.15
MACD -0.23 0.03
Stochastic Oscillator 0.45 80.47

Price Performance

Historical Comparison
LENZ
GEVO

About LENZ LENZ Therapeutics Inc.

LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

About GEVO Gevo Inc.

Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.

Share on Social Networks: